I think we've lost any regulatory function that the FDA had. People need to be very careful now with pharmaceutical drugs. I don't imagine doctors have done the dive that you have. If anyone questions a doctor, your articles are so valuable to print out and hand to them. For some doctors, it will be the only way they will be educated about how low the FDA and CDC have fallen.
I think we're just starting to notice how faulty a lot of these regulatory practices have been, to be honest. You hear of several controversies appearing in past years, but with COVID and the scrutiny that the vaccines have gotten it's just become more noticeable that there's a lot of failures in the approval process. But moving forward we're adding on the additional fact that an accelerated approval precedent has been set: take a disease that people desperately want gone, provide them a drug irrespective of its actual safety and efficacy, and push it through by means of the public's hope and want of a drug. It's the same tactics we saw with the vaccines being used for these immunotherapies, and likely for Ozempic which may see accelerated approval for other uses.
I hope some doctors see this. Hopefully it sort of puts into context that a lot of this is for show and they really can't provide any clear indication of actual, real-world efficacy. I've seen some people on Substack, including people who were heavily critical of the vaccines, talking positively of Leqembi. I think it's because most people just look at "statistically meaningful" and just stop there without thinking of clinically meaningful, or the side effects, costs and the like associated with this drug.
I wasn't sure what you were referring to and went to look it up. I think I heard of Cassava before, but I haven't looked closely into the poor science that is being alleged. All I can say with respect to Leqembi is that we don't need to look outside of Eisai's own drug arsenal to see red flags as Adulhelm is pretty much similar to Leqembi and yet that drug had a ton of controversies, but rather than compare the two and raise questions as to why Leqembi is receiving such praise when it is comparable to Adulhelm most people seem to have obfuscated this issue.
I do think the degree of investigations occurring with Cassava does raise some interesting things worth considering within the context of Biogen/Eisai and if there was any insider things going on. There were comments with people in the FDA possibly helping Biogen in navigating accelerated approval for Adulhelm, and a congressional committee investigated these issues as well, so I'm curious if these sorts of investigations just end there and Leqembi just goes right on through the approval process.
I think we've lost any regulatory function that the FDA had. People need to be very careful now with pharmaceutical drugs. I don't imagine doctors have done the dive that you have. If anyone questions a doctor, your articles are so valuable to print out and hand to them. For some doctors, it will be the only way they will be educated about how low the FDA and CDC have fallen.
I think we're just starting to notice how faulty a lot of these regulatory practices have been, to be honest. You hear of several controversies appearing in past years, but with COVID and the scrutiny that the vaccines have gotten it's just become more noticeable that there's a lot of failures in the approval process. But moving forward we're adding on the additional fact that an accelerated approval precedent has been set: take a disease that people desperately want gone, provide them a drug irrespective of its actual safety and efficacy, and push it through by means of the public's hope and want of a drug. It's the same tactics we saw with the vaccines being used for these immunotherapies, and likely for Ozempic which may see accelerated approval for other uses.
I hope some doctors see this. Hopefully it sort of puts into context that a lot of this is for show and they really can't provide any clear indication of actual, real-world efficacy. I've seen some people on Substack, including people who were heavily critical of the vaccines, talking positively of Leqembi. I think it's because most people just look at "statistically meaningful" and just stop there without thinking of clinically meaningful, or the side effects, costs and the like associated with this drug.
Is LEQEMBI news competitive w Casava forthcoming news?
I wasn't sure what you were referring to and went to look it up. I think I heard of Cassava before, but I haven't looked closely into the poor science that is being alleged. All I can say with respect to Leqembi is that we don't need to look outside of Eisai's own drug arsenal to see red flags as Adulhelm is pretty much similar to Leqembi and yet that drug had a ton of controversies, but rather than compare the two and raise questions as to why Leqembi is receiving such praise when it is comparable to Adulhelm most people seem to have obfuscated this issue.
I do think the degree of investigations occurring with Cassava does raise some interesting things worth considering within the context of Biogen/Eisai and if there was any insider things going on. There were comments with people in the FDA possibly helping Biogen in navigating accelerated approval for Adulhelm, and a congressional committee investigated these issues as well, so I'm curious if these sorts of investigations just end there and Leqembi just goes right on through the approval process.
Doctors Are Obedient By Nature
Therein Lies The Problem.
A fitting analog is that even in their "resistence"
they are addressing symptoms - not curing the disease:
Namely the medical lies they were taught,
the medical lies they believed,
and the medical lies they told others.
Without a confession of their sins
not a single one of these doctors will recover.